You are here

AusPAR: Atezolizumab

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

18 June 2020
AusPAR Details
AusPAR
Active Ingredient
Atezolizumab
Product Name
Tecentriq
Sponsor
Roche Products Pty Limited
Submission Number
PM-2019-00505-1-4
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
4 June 2020
Publication Date

18 June 2020